HSBC Holdings
PRAX icon

HSBC Holdings’s Praxis Precision Medicines PRAX Stock Holding History

HSBC Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Buy
1,634
+809
+98% +$250K ﹤0.01% 2204
2025
Q4 		$244K Sell
825
-10,347
-93% -$1.93M ﹤0.01% 2604
2025
Q3 		$595K Buy
+11,172
New +$542K ﹤0.01% 2017

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HSBC Holdings's PRAX Position: Q1 2026 in Review

HSBC Holdings increased its Praxis Precision Medicines (PRAX) stake by 98% in Q1 2026, buying an estimated $250K and bringing the position to 1,634 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

HSBC Holdings first reported a position in PRAX in Q3 2025 and has held it in 3 quarters since. The position peaked at $595K in Q3 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • HSBC Holdings held 1,634 shares of Praxis Precision Medicines worth $518K as of Q1 2026.
  • HSBC Holdings bought 809 Praxis Precision Medicines shares in Q1 2026, an estimated $250K.
  • Praxis Precision Medicines made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2204 holding.
  • HSBC Holdings first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 3 quarters since.
  • HSBC Holdings's Praxis Precision Medicines position peaked at $595K in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.